The potential role of HSP70 as an indicator of response to radiation and hyperthermia treatments for recurrent breast cancer

References

• Anderson R. L., Shiu E., Fisher G. A., Hahn G. M. DNA damage does not appear to be a trigger for thermotolerance in mammalian cells. International Journal of Radiation Biology 1988; 54: 285–298
   PubMed Web of Science ®Google Scholar
• Ciocca D. R., Clark G. M., Tandon A. K., Fuqua S. A. W., Welch W. J., McGuire W. L. Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. Journal of the National Cancer Institute 1993; 85: 570–574
   PubMed Web of Science ®Google Scholar
• Emami B., Myerson R. J., Cardenes H., Paris K. G., Perez C. A., Straube W., Leybovich L., Mildenberger M., Kuske R. R., Devineni V. R., Kucik N. Combined hyperthermia and irradiation in the treatment of superficial tumors: results of a prospective randomized trial of hyperthermia fractionation (1/wk vs 2/wk). International Journal of Radiation Oncology, Biology and Physics 1992; 24: 145–152
   PubMed Web of Science ®Google Scholar
• Engin K., Tupchong L, Moylan D. J., Alexander G. A., Waterman E. M., Komarnicky L., Nerlinger R. E., Leeper D. B. Randomized trial of one versus two adjuvant hyperthermia treatments per week in patients with superficial tumours. International Journal of Hyperthermia 1993; 9: 327–340
   PubMed Web of Science ®Google Scholar
• Hahn G. M. Hyperthermia and Cancer. Plenum Press, New York 1982
   Google Scholar
• Hahn G. M., Shiu E. C., West B., Goldstein L., Li G. C. Mechanistic implications of the induction of thermotolerance in Chinese hamster cells by organic solvents. Cancer Research 1985; 45: 4138–4143
   PubMed Web of Science ®Google Scholar
• Hurlimann J., Gebhard S., Gomez F. Oestrogen receptor, progesterone receptor, pS2, ERD5, HSP27 and cathepsin D in invasive ductal breast carcinomas. Histopathology 1993; 23: 239–248
   PubMedGoogle Scholar
• Kapp D. S., Petersen I. A., Cox R. S., Hahn G. M., Fessenden P., Prionas S. D., Lee E. R., Meyer J. L., Samulski T. V., Bagshaw M. A. Two or six hyperthermia treatments as an adjunct to radiation therapy yield similar tumor responses: results of a randomized trial. International Journal of Radiation, Oncology, Biology and Physics 1990; 19: 1481–1495
   PubMed Web of Science ®Google Scholar
• Kimura E., Enns R. E., Alcaraz J. E., Arboleda J., Slamon D. J., Howell S. B. Correlation of the survival of ovarian cancer patients with mRNA expression of the 60-kD heat-shock protein HSP-60. Journal of Clinical Oncology 1993; 11: 891–898
   PubMed Web of Science ®Google Scholar
• Lehmann E. L. Non-parametrics: Statistical methods based on ranks. Holden-Day, San Francisco 1975; 23–31
   Google Scholar
• Leopold K. A., Harrelson J., Prosnitz L., Samulski T. V., Dewhirst M. W., Oleson J. R. Preoperative hyperthermia and radiation for soft tissue sarcomas: Advantage of two vs one hyperthermia treatments per week. International Journal of Radiation Oncology, Biology and Physics 1989; 16: 107–115
   PubMed Web of Science ®Google Scholar
• Li G. C., Werb Z. Correlation between the synthesis of heat-shock protein and the development of thermotolerance in Chinese hamster fibroblasts. Proceedings of the National Academy of Sciences, USA 1982; 79: 3219–3222
   Google Scholar
• Lindquist S., Craig E. A. The heat-shock proteins. Annual Review of Genetics 1988; 22: 631–677
   PubMed Web of Science ®Google Scholar
• Love S., King R. J. B. A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer. British Journal of Cancer 1994; 69: 743–748
   PubMedGoogle Scholar
• Marquez C. M., Sneed P. K., Li G. C., Mak H. Y., Phillips T. L. HSP70 synthesis in clinical hyperthermia patients: Preliminary results of a new technique. International Journal of Radiation Oncology, Biology and Physics 1993; 28: 425–430
   Google Scholar
• Miller A. B., Hoogstraten G., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207–214
   PubMed Web of Science ®Google Scholar
• Morimoto R. I. Cells in stress: Transcriptional activation of heat shock genes. Sciences 1993; 259: 1409–1410
   PubMed Web of Science ®Google Scholar
• Oleson J. R., Samulski T. V., Leopold K. A., Clegg S. T., Dewhirst M. W., Dodge R. K., George S. L. Sensitivity of hyperthermia trial outcomes to temperature and time: Implications for thermal goals of treatment. International Journal of Radiation Oncology, Biology and Physics 1993; 25: 289–297
   PubMed Web of Science ®Google Scholar
• Raaphorst G. P., Azzam E. I. Evaluation of thermoradiosensitization and transformation in C3H-10T1/2 cells induced into a thermotolerant state. International Journal of Hyperthermia 1988; 4: 345–354
   PubMed Web of Science ®Google Scholar
• Riabowol K. T., Mizzen L. A., Welch W. J. Heat shock is lethal to fibroblasts microinjected with antibodies against HSP70. Science 1988; 242: 433–436
   PubMed Web of Science ®Google Scholar
• Sapareto S. A., Dewey W. C. Thermal dose determination in cancer therapy. International Journal of Radiation Oncology, Biology and Physics 1984; 10: 787–800
   PubMed Web of Science ®Google Scholar
• Storm F. K., Mahvi D. M., Gilchrist K. W. HSP-27 has no diagnostic or prognostic significance in prostate or bladder cancers. Urology 1993; 42: 379–382
   PubMedGoogle Scholar
• Takahashi S., Mikami T., Watanabe Y., Okazaki M., Okazaki Y., Okazaki A., Sato T., Asaishi K., Hirata K., Narimatsu E., et al. Overexpression of 70-kD heat-shock protein (HSP70) correlates with estrogen receptor levels in invasive human breast cancer. FASEB J 1992; 6: A1927, (Abstr)
   Google Scholar
• Tetu B., Lacasse B., Bouchard H-L., Lagace R., Huot J., Landry J. Prognostic influence of HSP-27 expression in malignant fibrous histiocytoma: A clinicopathological and immunohistochemical study. Cancer Research 1992; 52: 2325–2328
   PubMedGoogle Scholar
• Thor A., Benz C., Moore D., II, Goldman E., Edgerton S., Landry J., Schwartz L, Mayall B., Hickey E., Weber L. A. Stress response protein (srp-27) determination in primary human breast carcinoma: clinical, histologic, and prognostic correlations. Journal of the National Cancer Institute 1991; 83: 170–178
   PubMed Web of Science ®Google Scholar
• Ungar D. R., Hailat N., Strahler J. R., Kuick R. D., Brodeur G. M., Seeger R. C., Reynolds C. P., Hanash S. M. Hsp27 expression in neuroblastoma: Correlation with disease stage. Journal of the National Cancer Institute 1994; 86: 780–784
   PubMedGoogle Scholar
• Valdagni R. Two versus six hyperthermia treatments in combination with radical irradiation for fixed metastatic nodes: Progress Report. Recent Results in Cancer Research. (Springer-Verlag), Berlin-Heidelberg 1988; 107: 123–128
   Google Scholar
• Vernon C. C. Collaborative phase III superficial hyperthermia trial (MRC/ESHO/DDHK/PMH). 14th Annual Meeting of the North American Hyperthermia Society, Nashville, TN, 1994; 87
   Google Scholar
• Wilson C., Jr, Lee J. C., Li G. C. The survival response of rodent cells expressing human HSP70 after exposure to X-rays. Thirteenth Annual Meeting of the North American Hyperthermia Society. 1993; 32
   Google Scholar
• Woo S. Y., Rice G. C., Kapp D. S., Hahn G. M. A predictive assay for human tumor cellular response to hyperthermia using dansyl lysine staining and flow cytometry. International Journal of Radiation Oncology, Biology and Physics 1988; 14: 361–365
   PubMedGoogle Scholar
• Woo S. Y., Anderson R. L., Kapp D. S., Van Kersen L., Rice G. C., Krag D. N., Hahn G. M. Heterogeneity of heat response in murine, canine and human tumors: influence on predictive assays. International Journal of Radiation Oncology, Biology and Physics 1991; 20: 479–488
   PubMedGoogle Scholar
• Yatvin M. B., Clifton K. H., Dennis W. H. Hyperthermia and local anesthetics: potentiation of survival in tumor-bearing mice. Science 1979; 205: 195–196
   PubMed Web of Science ®Google Scholar